Connection
Adam Corken to Treatment Outcome
This is a "connection" page, showing publications Adam Corken has written about Treatment Outcome.
|
|
Connection Strength |
|
|
|
|
|
0.026 |
|
|
|
-
Jain N, Corken A, Arthur JM, Ware J, Arulprakash N, Dai J, Phadnis MA, Davis O, Rahmatallah Y, Mehta JL, Hedayati SS, Smyth S. Ticagrelor inhibits platelet aggregation and reduces inflammatory burden more than clopidogrel in patients with stages 4 or 5 chronic kidney disease. Vascul Pharmacol. 2023 02; 148:107143.
Score: 0.026